Pfizer has notified Pain Therapeutics that it has decided to discontinue its agreement to develop and commercialize Remoxy (oxycodone) Extended-Release...
In 2008, Catalyst Biosciences signed a $500 million-plus deal to develop Factor VIIa therapies for hemophilia with Pfizer. However Pfizer...
Pfizer Inc. announced that the merger agreement between Pfizer and Allergan plc has been terminated by mutual agreement of the...
Pfizer Inc. and Hospira, Inc. announced that they have entered into a definitive merger agreement under which Pfizer will acquire...
Pfizer Inc. and Allergan plc announced that their boards of directors have unanimously approved, and the companies have entered into,...
It is reported that Pfizer has offered �60 billion for AstraZeneca but that the approach was rejected. The aim of...
The Board of AstraZeneca PLC notes the announcement by Pfizer Inc. of its final proposal comprising £24.76 in cash (45%)...
The Board of AstraZeneca PLC notes the announcement made by Pfizer Inc.. Pfizer’s announcement contains no new proposal nor substantive...
Pfizer Inc has. announced that the FDA has approved Duavee (conjugated oestrogens/bazedoxifene) 0.45mg / 20mg tablets, a novel therapy for...
On 16 May 2014, Pfizer sent a letter to the Chairman of AstraZeneca setting forth the terms and basis of...